Owkin announced on September 2, 2026 that it has entered a license agreement with Boehringer Ingelheim covering K Pro, Owkin's AI Scientist for biopharma research, together with multimodal patien [...]
One of the ultimate goals of medieval alchemy has been realized, but only for a fraction of a second. Scientists with the European Organization for Nuclear Research, better known as CERN, were able to [...]
Test-time scaling (TTS) has emerged as a proven method to improve the performance of large language models in real-world applications by giving them extra compute cycles at inference time. However, TT [...]